FOCLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
EDAP TMS SA
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Aug 14, 2026
$4.07−0.02 (-0.49%)
Close on Oct 19, 2026
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
41.5%
16M of 38M shares
Institutional holders
37
6 new, 5 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
9 buys · 0 sales
Net bought $593.20K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Guy Levy | 7,309,254 | 19.70% | 13G (passive) amendment | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of FOCL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. | 7,309,254 | 19.48% | $37.86M | – | 1.30% |
| Morgan Stanley | 3,336,872 | 8.89% | $17.28M | −8,408 | 0.00% |
| Flax Pond Capital, LLC | 1,525,676 | 4.07% | $6.75M | +742,230 | 2.50% |
| Rock Springs Capital Management LP | 1,386,000 | 3.69% | $7.18M | +8,000 | 0.35% |
| Bruce & Co., Inc. | 438,652 | 1.17% | $2.27M | – | 0.61% |
| Parkman Healthcare Partners LLC | 154,832 | 0.41% | $802.03K | – | 0.08% |
| Essex Investment Management Co LLC | 146,005 | 0.39% | $756.31K | New | 0.10% |
| Cahill Financial Advisors Inc | 134,960 | 0.36% | $699.09K | – | 0.07% |
| US Bancorp \de\ | 122,500 | 0.33% | $634.55K | +3,500 | 0.00% |
| UBS Group AG | 118,395 | 0.32% | $613.29K | −51,235 | 0.00% |
| Sage Mountain Advisors LLC | 100,000 | 0.27% | $518.00K | – | 0.03% |
| Leonteq Securities AG | 94,990 | 0.25% | $492.05K | – | 0.02% |
| Summit Trail Advisors, LLC | 82,339 | 0.22% | $426.52K | −20,000 | 0.01% |
| Cetera Investment Advisers | 74,012 | 0.20% | $383.38K | – | 0.00% |
| Commonwealth Equity Services, LLC | 69,160 | 0.18% | $358.25K | – | 0.00% |
| Citadel Advisors LLC | 66,183 | 0.18% | $342.83K | New | 0.00% |
| Legato Capital Management LLC | 48,269 | 0.13% | $250.03K | New | 0.02% |
| Osaic Holdings, Inc. | 42,700 | 0.11% | $221.19K | – | 0.00% |
| Schonfeld Strategic Advisors LLC | 41,730 | 0.11% | $216.16K | +15,869 | 0.00% |
| Manatuck Hill Partners, LLC | 27,597 | 0.07% | $142.95K | – | 0.05% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 37 | 16M | 41.5% | 6 / 9 | 5 / 5 | 1M | 0M |
| Q1 2026 | 36 | 15M | 38.8% | 6 / 5 | 6 / 2 | 0M | 0M |
| Q4 2025 | 33 | 15M | 38.9% | 4 / 2 | 9 / 5 | 1M | 0M |
| Q3 2025 | 34 | 14M | 36.8% | 1 / 3 | 9 / 3 | 0M | 0M |
| Q2 2025 | 36 | 14M | 37.6% | 7 / 2 | 5 / 5 | 0M | 1M |
| Q1 2025 | 34 | 15M | 39.2% | 5 / 5 | 7 / 6 | 0M | 1M |
| Q4 2024 | 35 | 15M | 41.1% | 6 / 7 | 12 / 5 | 0M | 1M |
| Q3 2024 | 34 | 16M | 41.8% | 6 / 8 | 7 / 6 | 0M | 1M |
| Q2 2024 | 35 | 16M | 42.8% | 2 / 7 | 11 / 5 | 0M | 7M |
| Q1 2024 | 38 | 23M | 61.3% | 7 / 9 | 7 / 4 | 4M | 0M |
| Q4 2023 | 35 | 19M | 51.8% | 1 / 10 | 11 / 9 | 5M | 1M |
| Q3 2023 | 43 | 16M | 42.4% | 4 / 11 | 18 / 14 | 1M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of FOCL | Value | % of fund | As of |
|---|---|---|---|---|---|
| Bruce Fund | 414,794 | 1.11% | $2.15M | 0.57% | Jun 30, 2026 |
| 1290 Essex Small Cap Growth Fund | 124,974 | 0.33% | $764.84K | 0.66% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 22,764 | 0.06% | $98.57K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ryan Rhodes | Chief Executive Officer, Director | 626,649 | 1.67% | Aug 17, 2026 |
| Steven Annen | SVP, Marketing & Product Mgmt. | 136,490 | 0.36% | Aug 17, 2026 |
| Sanket Shah | General Counsel & Corp Sec | 72,500 | 0.19% | Aug 17, 2026 |
| Kenneth S. Mobeck | Chief Financial Officer | 181,610 | 0.48% | Aug 17, 2026 |
| Francois Mattieu Dietsch | Chief Accounting Officer | 12,000 | 0.03% | Jan 13, 2026 |
| David R. Horn | Director | 10,000 | 0.03% | Aug 17, 2026 |
| Fran Schulz | Director | 15,100 | 0.04% | Aug 17, 2026 |
| Joshua Levine | Director | 45,000 | 0.12% | Aug 17, 2026 |
| Lance Willsey | Director | 1,291,780 | 3.44% | Aug 17, 2026 |
| Glendon E. French III | Director | – | – | Jan 9, 2026 |
| Soleus Capital Master Fund, L.P. | 10% owner | – | – | Aug 20, 2026 |
| Soleus Private Equity Fund III, L.P. | 10% owner | – | – | Aug 20, 2026 |
| Soleus Capital Management, L.P. | 10% owner | – | – | Aug 20, 2026 |
| Soleus Capital Group, LLC | 10% owner | – | – | Aug 20, 2026 |
| Soleus Private Equity GP III, LLC | 10% owner | – | – | Aug 20, 2026 |
| Soleus PE GP III, LLC | 10% owner | – | – | Aug 20, 2026 |
| Soleus Capital, LLC | 10% owner | – | – | Aug 20, 2026 |
| Guy Levy | 10% owner | 1,400,000 | 3.73% | Aug 20, 2026 |
| Soleus GP, LLC | 10% owner | – | – | Aug 20, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Sanket Shah General Counsel & Corp Sec | Aug 14, 2026 | Buy | +5,000 | $4.75 | $23.75K | 72,500 |
| Lance Willsey Director | Aug 14, 2026 | Buy | +50,000 | $4.75 | $237.50K | 1,291,780 |
| Joshua Levine Director | Aug 14, 2026 | Buy | +10,000 | $4.75 | $47.50K | 45,000 |
| Fran Schulz Director | Aug 14, 2026 | Buy | +10,000 | $4.75 | $47.50K | 15,100 |
| Ryan Rhodes Chief Executive Officer, Director | Aug 14, 2026 | Buy | +21,000 | $4.75 | $99.75K | 626,649 |
| David R. Horn Director | Aug 14, 2026 | Buy | +10,000 | $4.75 | $47.50K | 10,000 |
| Kenneth S. Mobeck Chief Financial Officer | Aug 14, 2026 | Buy | +5,000 | $4.75 | $23.75K | 181,610 |
| Steven Annen SVP, Marketing & Product Mgmt. | Aug 14, 2026 | Buy | +5,000 | $4.75 | $23.75K | 136,490 |
| Steven Annen SVP, Marketing & Product Mgmt. | May 12, 2026 | Award | +90,000 | – | – | 131,490 |
| Sanket Shah Gen Counsel & Corp Secretary | May 12, 2026 | Award | +67,500 | – | – | 67,500 |
| Ryan Rhodes Chief Executive Officer, Director | May 12, 2026 | Award | +304,500 | – | – | 605,649 |
| Kenneth S. Mobeck Chief Financial Officer | May 12, 2026 | Award | +120,000 | – | – | 176,610 |
| Joshua Levine Director | May 11, 2026 | Buy | +10,000 | $4.22 | $42.20K | 35,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Willsey Lance Director | Nov 26, 2024 | 30,000 | $74.16K | Nov 26, 2024 | Open Market Purchase |
| Lance Willsey Director | Nov 25, 2024 | 22,702 | $56.74K | Nov 25, 2024 | Open market |
| Willsey Lance Director | Nov 22, 2024 | 11,388 | $29.07K | Nov 22, 2024 | Open Market Purchase |
| Willsey Lance Director | Nov 21, 2024 | 10,000 | $24.84K | Nov 21, 2024 | Open Market Purchase |
| Willsey Lance Director | Nov 20, 2024 | 20,000 | $50.55K | Nov 20, 2024 | Open Market Purchase |
| Willsey Lance Director | Nov 19, 2024 | 15,010 | $36.92K | Nov 19, 2024 | Open Market Purchase |
| Willsey Lance Director | Nov 18, 2024 | 20,000 | $49.41K | Nov 18, 2024 | Open Market Purchase |
| Willsey Lance Director | Nov 15, 2024 | 21,000 | $52.92K | Nov 15, 2024 | Open Market Purchase |
| Willsey Lance Director | Nov 14, 2024 | 10,000 | $25.62K | Nov 14, 2024 | Open Market Purchase |
| Willsey Lance Director | Nov 13, 2024 | 9,900 | $25.52K | Nov 13, 2024 | Open Market Purchase |